Safety, immunogenicity and efficacy of modified vaccinia Ankara (MVA) against Dryvax® challenge in vaccinia-naive and vaccinia-immune individuals

被引:77
作者
Parrino, Janie
McCurdy, Lewis H.
Larkin, Brenda D.
Gordon, Ingelise J.
Rucker, Steven E.
Enama, Mary E.
Koup, Richard A.
Roederer, Mario
Bailer, Robert T.
Moodie, Zoe
Gu, Lin
Yan, Lihan
Graham, Barney S.
机构
[1] NIAID, Vaccine Res Ctr, NIH, Bethesda, MD 20892 USA
[2] Stat Ctr HIV AIDS Res & Prevent, Seattle, WA USA
[3] EMMEs Corp, Rockville, MD USA
关键词
smallpox; orthopoxvirus; vaccine;
D O I
10.1016/j.vaccine.2006.10.047
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Modified vaccinia Ankara (MVA) was evaluated as an alternative to Dryvax (R) in vaccinia-naive and vaccinia-immune adult volunteers. Subjects received intramuscular MVA or placebo followed by Dryvax (R) challenge at 3 months. Two or more doses of MVA prior to Dryvax (R) reduced severity of lesion formation, decreased magnitude and duration of viral shedding, and augmented post-Dryvax (R) vaccinia-specific CD8+ T cell responses and extracellular enveloped virus protein-specific antibody responses. MVA vaccination is safe and immunogenic and improves the safety and immunogenicity of subsequent Dryvax (R) vaccination supporting the potential for using MVA as a vaccine in the general population to improve immunity to orthopox viruses. Published by Elsevier Ltd.
引用
收藏
页码:1513 / 1525
页数:13
相关论文
共 21 条
[1]   Myopericarditis following smallpox vaccination [J].
Arness, MK ;
Eckart, RE ;
Love, SS ;
Atwood, JE ;
Wells, TS ;
Engler, RJM ;
Collins, LC ;
Ludwig, SL ;
Riddle, JR ;
Grabenstein, JD ;
Tornberg, DN .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 160 (07) :642-651
[2]   Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses [J].
Belyakov, IM ;
Earl, P ;
Dzutsev, A ;
Kuznetsov, VA ;
Lemon, M ;
Wyatt, LS ;
Snyder, JT ;
Ahlers, JD ;
Franchini, G ;
Moss, B ;
Berzofsky, JA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (16) :9458-9463
[3]   Mucosal immune response to trivalent live attenuated intranasal influenza vaccine in children [J].
Boyce, TG ;
Gruber, WC ;
Coleman-Dockery, SD ;
Sannella, EC ;
Reed, GW ;
Wolff, M ;
Wright, PF .
VACCINE, 1999, 18 (1-2) :82-88
[4]  
*CDC, 2002, GUID B VACC GUID STA
[5]   Threats in bioterrorism I: CDC category A agents [J].
Darling, RG ;
Catlett, CL ;
Huebner, KD ;
Jarrett, DG .
EMERGENCY MEDICINE CLINICS OF NORTH AMERICA, 2002, 20 (02) :273-+
[6]   Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox [J].
Earl, PL ;
Americo, JL ;
Wyatt, LS ;
Eller, LA ;
Whitbeck, JC ;
Cohen, GH ;
Eisenberg, RJ ;
Hartmann, CJ ;
Jackson, DL ;
Kulesh, DA ;
Martinez, MJ ;
Miller, DM ;
Mucker, EM ;
Shamblin, JD ;
Zwiers, SH ;
Huggins, JW ;
Jahrling, PB ;
Moss, B .
NATURE, 2004, 428 (6979) :182-185
[7]   Smallpox vaccine-induced antibodies are necessary and sufficient for protection against monkeypox virus [J].
Edghill-Smith, Y ;
Golding, H ;
Manischewitz, J ;
King, LR ;
Scott, D ;
Bray, M ;
Nalca, A ;
Hooper, JW ;
Whitehouse, CA ;
Schmitz, JE ;
Reimann, KA ;
Franchini, G .
NATURE MEDICINE, 2005, 11 (07) :740-747
[8]   Modeling a safer smallpox vaccination regimen, for human immunodeficiency virus type 1-infected patients, in immunocompromised Macaques [J].
Edghill-Smith, Y ;
Venzon, D ;
Karpova, T ;
McNally, J ;
Nacsa, J ;
Tsai, WP ;
Tryniszewska, E ;
Moniuszko, M ;
Manischewitz, J ;
King, LR ;
Snodgrass, SJ ;
Parrish, J ;
Markham, P ;
Sowers, M ;
Martin, D ;
Lewis, MG ;
Berzofsky, JA ;
Belyakov, IM ;
Moss, B ;
Tartaglia, J ;
Bray, M ;
Hirsch, V ;
Golding, H ;
Franchini, G .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (08) :1181-1191
[9]   VACCINATION OF VACCINIA-NAIVE ADULTS WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 GP160 RECOMBINANT VACCINIA VIRUS IN A BLINDED, CONTROLLED, RANDOMIZED CLINICAL-TRIAL [J].
GRAHAM, BS ;
BELSHE, RB ;
CLEMENTS, ML ;
DOLIN, R ;
COREY, L ;
WRIGHT, PF ;
GORSE, GJ ;
MIDTHUN, K ;
KEEFER, MC ;
ROBERTS, NJ ;
SCHWARTZ, DH ;
AGOSTI, JM ;
FERNIE, BF ;
STABLEIN, DM ;
MONTEFIORI, DC ;
LAMBERT, JS ;
HU, SL ;
ESTERLITZ, JR ;
LAWRENCE, DN ;
KOFF, WC .
JOURNAL OF INFECTIOUS DISEASES, 1992, 166 (02) :244-252
[10]  
Greenberg RN, 2005, LANCET, V365, P398, DOI 10.1016/S0140-6736(05)70234-8